Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.
Not Applicable
- Conditions
- Acute decompensated heart failure
- Registration Number
- JPRN-UMIN000028039
- Lead Sponsor
- Iiyama redcross hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Under 75 2.Hypersensitivity for Tolvaptan or Mozavaptan. 3.Anuria 4.Insensitivity to thurst of difficulty in water in take. 5.Patients who already have tolvaptan at entry. 6.Severe coronary arterydisease and cerebrovascular disease. 7.Severe renal failure 8.Hypernatremia(serum Na>146mEq/L)and(serum Na<125mEq/L). 9.Hyperkalemia(serum K>5.5mEq/L)and(serum K<3.0mEq/L). 10.Chronic hepatitis Liver dysfunction(pharmacological etc.). 11.Hepatic encephalopathy. 12.Any conditions inappropriate to this trial deemed by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in circulating plasma volume by IVC.
- Secondary Outcome Measures
Name Time Method